 |
 |
 |
Search IPO GMP:
Bio Medica Laboratories IPO GMP
Bio Medica Laboratories IPO is an SME IPO, the company will raise up to 52 crore 43 lakh 8 thousand rupees for 37,72,000 shares. The IPO comprises a fresh issue of 33,95,000 shares (aggregating up to 47 crore 19 lakh 5 thousand rupees), and an offer for sale (OFS) of 3,77,000 shares (aggregating up to 5 crore 24 lakh 3 thousand rupees).
| Bio Medica Laboratories IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹132 to ₹139 per share |
Bio Medica Laboratories IPO Latest GMP (Grey Market Premium) Today
Visit us daily to get the latest update on IPO GMP. You will get the latest update of SME IPO GMP.
Bio Medica Laboratories IPO Lates GMP (grey market premium) available here
- Price Band of Bio Medica Laboratories IPO is ₹132 to ₹139 per share.
- Current GMP (Grey Market Premium) for Bio Medica Laboratories IPO is:
- It is a premium for the IPO cut-off price .
- As per Bio Medica Laboratories IPO Taday’s GMP Data, the estimated listing price of Bio Medica Laboratories IPO shares can be:
- Estimated listing price calculated as Bio Medica Laboratories IPO cutoff price or allotment price: ₹139 per share + IPO current GMP: .
Bio Medica Laboratories SME IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | -6 | |
| 27 May 2026 | -6 | |
| 26 May 2026 | -6 | |
| 25 May 2026 | 0 | |
| 24 May 2026 | 0 | |
| 23 May 2026 | 0 | |
| 22 May 2026 | 3 | |
| 21 May 2026 | 2.50 | |
| 20 May 2026 | 0 | |
| 19 May 2026 | 0 | |
| 18 May 2026 | 0 | |
| 17 May 2026 | 0 | |
Total shares offered by Bio Medica Laboratories IPO is 37,72,000 shares (aggregating up to 52 crore 43 lakh 8 thousand rupees). Out of which 17,92,000 shares (47.51%) is reserved for retail, 17,55,000 shares (46.53%) is reserved for HNI (NII), 36,000 shares (0.95%) is reserved for QIB, and 1,89,000 shares (5.01%) is reserved for market maker Prabhat Financial Services Ltd.
Bio Medica Laboratories IPO will open for subscription on 21 May 2026 and close on 25 May 2026. Basis of allotment will be decided on 26 May 2026, initiation of refund will begin on 27 May 2026 and finally IPO will be listed on 29 May 2026 at NSE SME. Narnolia Financial Services Ltd is the book running lead manager and Skyline Financial Service Pvt Ltd is the registrar of the Bio Medica Laboratories IPO.
Bio Medica Laboratories IPO Price Band and Market Lot
Bio Medica Laboratories has set a price band of ₹132 to ₹139 per share and lot size is of 1000. Retail investors can bid for a minimum and maximum of 2 lots (2,000 shares), requiring an investment of ₹2,78,000, sHNI investors can bid for a minimum of 3 lots (3,000 shares), requiring an investment of ₹4,17,000 and bHNI investors can bid for a minimum of 8 Lots (8,000 shares), requiring an investment of ₹11,12,000 calculated at the cut-off price ₹139 per share (the upper end of the price band).
| Bio Medica Laboratories IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹132 to ₹139 per share |
| Lot Size | 1,000 shares |
| IPO Issue Type | Book Built Issue |
About Bio Medica Laboratories
Bio Medica Laboratories Limited is a prominent parenteral (injectable) pharmaceutical manufacturer based in Central India, headquartered in Indore, Madhya Pradesh. The company is renowned for its commitment to excellence, innovation, and adherence to strict Good Manufacturing Practices (GMP and GLP) in producing high-quality parenteral formulations.Bio Medica Laboratories IPO GMP FAQs
The latest Grey Market Premium (GMP) of Bio Medica Laboratories IPO is .
It is a premium to the IPO cut-off price Bio Medica Laboratories. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Bio Medica Laboratories IPO can be .
Expected listing listing price for Bio Medica Laboratories share can be .
According to latest GMP data pattern expected listing price and profit per share for Bio Medica Laboratories IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell IPO forms in the grey market and GMP prices shown here are gathered from various sources.